BMO Capital Markets initiated coverage on Dyne Therapeutics (DYN, Financials) with an Outperform rating and a $50 price target, suggesting a strong upside from the company's current share price of ...

Telos (NASDAQ:TLS – Get Free Report) had its target price lowered by analysts at BMO Capital Markets from $4.50 to $3.00 in a research note issued to investors on Tuesday,Benzinga reports.

BMO Capital Markets’ price target suggests a potential upside of 24.89% from the stock’s current price. A number of other brokerages have also issued reports on PTGX.

Investing.com -- BMO Capital Markets upgraded Century Aluminum Company (NASDAQ:CENX) to "Outperform" from "Market Perform" given its favourable valuation following a recent sell-off and the ...

BMO Capital raised the firm’s price target on Okta (OKTA) to $130 from $105 and keeps a Market Perform rating on the shares. The firm had been ...

A cooler-than-expected February consumer-price index is stoking a relief bounce in stock-index futures and triggered an initial surge higher in Treasurys, which pulled down yields, which move opposite ...

BMO Capital upgraded Goeasy (EHMEF) to Outperform from Market Perform with a price target of C$200, down from C$207. Goeasy trades at trough multiples on tariff-scenario earnings, effectively ...